 | • レポートコード：QYR2104Z2860 • 出版社/出版日：QYResearch / 2021年4月10日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、HIV治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ヌクレオシドアナログ逆転写酵素阻害剤（NRTI）、非ヌクレオシド逆転写酵素阻害剤（NNRTI）、侵入・融合阻害剤、プロテアーゼ阻害剤（PI）、インテグラーゼ阻害剤、共受容体拮抗薬）、用途別市場規模（病院、クリニック、研究所）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・HIV治療の市場動向 ・企業の競争状況、市場シェア ・HIV治療の種類別市場規模（ヌクレオシドアナログ逆転写酵素阻害剤（NRTI）、非ヌクレオシド逆転写酵素阻害剤（NNRTI）、侵入・融合阻害剤、プロテアーゼ阻害剤（PI）、インテグラーゼ阻害剤、共受容体拮抗薬） ・HIV治療の用途別市場規模（病院、クリニック、研究所） ・HIV治療の北米市場規模2016-2027（アメリカ、カナダ） ・HIV治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・HIV治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・HIV治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・HIV治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Boehringer Ingelheim International GmbH、Merck & Co.、ViiV Healthcare、AbbVie、F. Hoffmann-La Roche Ltd.、Teva Pharmaceutical Industries Ltd.、Bristol-Myers Squibb、Gilead Sciences、Johnson & Johnson、Cipla Limited） ・結論 |
The human immunodeficiency virus (HIV) refers to a type of retrovirus that causes acquired immunodeficiency syndrome (AIDS). HIV attacks some immune cells and causes weakness of immune system resulting in loss of ability to fight against the organism that causes disease.
HIV spreads through fluidic exchange with some infected person such as blood transfer or sharing needles with someone who is HIV infected. In addition, HIV can spread from infected mother to child during pregnancy. Some of the symptoms of HIV infection are slight fever, fatigue, swollen glands, headaches and muscle aches.
Market Analysis and Insights: Global HIV Therapeutics Market
The global HIV Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global HIV Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global HIV Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global HIV Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global HIV Therapeutics market.
Global HIV Therapeutics Scope and Market Size
HIV Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global HIV Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)
Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
Entry and Fusion Inhibitors
Protease Inhibitors (PIs)
Integrase Inhibitors
Coreceptor Antagonists
Segment by Application
Hospitals
Clinics
Labs
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Boehringer Ingelheim International GmbH
Merck & Co.
ViiV Healthcare
AbbVie
F. Hoffmann-La Roche Ltd.
Teva Pharmaceutical Industries Ltd.
Bristol-Myers Squibb
Gilead Sciences
Johnson & Johnson
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global HIV Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)
1.2.3 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
1.2.4 Entry and Fusion Inhibitors
1.2.5 Protease Inhibitors (PIs)
1.2.6 Integrase Inhibitors
1.2.7 Coreceptor Antagonists
1.3 Market by Application
1.3.1 Global HIV Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Labs
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global HIV Therapeutics Market Perspective (2016-2027)
2.2 HIV Therapeutics Growth Trends by Regions
2.2.1 HIV Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 HIV Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 HIV Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 HIV Therapeutics Industry Dynamic
2.3.1 HIV Therapeutics Market Trends
2.3.2 HIV Therapeutics Market Drivers
2.3.3 HIV Therapeutics Market Challenges
2.3.4 HIV Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top HIV Therapeutics Players by Revenue
3.1.1 Global Top HIV Therapeutics Players by Revenue (2016-2021)
3.1.2 Global HIV Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global HIV Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by HIV Therapeutics Revenue
3.4 Global HIV Therapeutics Market Concentration Ratio
3.4.1 Global HIV Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by HIV Therapeutics Revenue in 2020
3.5 HIV Therapeutics Key Players Head office and Area Served
3.6 Key Players HIV Therapeutics Product Solution and Service
3.7 Date of Enter into HIV Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 HIV Therapeutics Breakdown Data by Type
4.1 Global HIV Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global HIV Therapeutics Forecasted Market Size by Type (2022-2027)
5 HIV Therapeutics Breakdown Data by Application
5.1 Global HIV Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global HIV Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America HIV Therapeutics Market Size (2016-2027)
6.2 North America HIV Therapeutics Market Size by Type
6.2.1 North America HIV Therapeutics Market Size by Type (2016-2021)
6.2.2 North America HIV Therapeutics Market Size by Type (2022-2027)
6.2.3 North America HIV Therapeutics Market Size by Type (2016-2027)
6.3 North America HIV Therapeutics Market Size by Application
6.3.1 North America HIV Therapeutics Market Size by Application (2016-2021)
6.3.2 North America HIV Therapeutics Market Size by Application (2022-2027)
6.3.3 North America HIV Therapeutics Market Size by Application (2016-2027)
6.4 North America HIV Therapeutics Market Size by Country
6.4.1 North America HIV Therapeutics Market Size by Country (2016-2021)
6.4.2 North America HIV Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe HIV Therapeutics Market Size (2016-2027)
7.2 Europe HIV Therapeutics Market Size by Type
7.2.1 Europe HIV Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe HIV Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe HIV Therapeutics Market Size by Type (2016-2027)
7.3 Europe HIV Therapeutics Market Size by Application
7.3.1 Europe HIV Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe HIV Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe HIV Therapeutics Market Size by Application (2016-2027)
7.4 Europe HIV Therapeutics Market Size by Country
7.4.1 Europe HIV Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe HIV Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific HIV Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific HIV Therapeutics Market Size by Type
8.2.1 Asia-Pacific HIV Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific HIV Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific HIV Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific HIV Therapeutics Market Size by Application
8.3.1 Asia-Pacific HIV Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific HIV Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific HIV Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific HIV Therapeutics Market Size by Region
8.4.1 Asia-Pacific HIV Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific HIV Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America HIV Therapeutics Market Size (2016-2027)
9.2 Latin America HIV Therapeutics Market Size by Type
9.2.1 Latin America HIV Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America HIV Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America HIV Therapeutics Market Size by Type (2016-2027)
9.3 Latin America HIV Therapeutics Market Size by Application
9.3.1 Latin America HIV Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America HIV Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America HIV Therapeutics Market Size by Application (2016-2027)
9.4 Latin America HIV Therapeutics Market Size by Country
9.4.1 Latin America HIV Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America HIV Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa HIV Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa HIV Therapeutics Market Size by Type
10.2.1 Middle East & Africa HIV Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa HIV Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa HIV Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa HIV Therapeutics Market Size by Application
10.3.1 Middle East & Africa HIV Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa HIV Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa HIV Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa HIV Therapeutics Market Size by Country
10.4.1 Middle East & Africa HIV Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa HIV Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Boehringer Ingelheim International GmbH
11.1.1 Boehringer Ingelheim International GmbH Company Details
11.1.2 Boehringer Ingelheim International GmbH Business Overview
11.1.3 Boehringer Ingelheim International GmbH HIV Therapeutics Introduction
11.1.4 Boehringer Ingelheim International GmbH Revenue in HIV Therapeutics Business (2016-2021)
11.1.5 Boehringer Ingelheim International GmbH Recent Development
11.2 Merck & Co.
11.2.1 Merck & Co. Company Details
11.2.2 Merck & Co. Business Overview
11.2.3 Merck & Co. HIV Therapeutics Introduction
11.2.4 Merck & Co. Revenue in HIV Therapeutics Business (2016-2021)
11.2.5 Merck & Co. Recent Development
11.3 ViiV Healthcare
11.3.1 ViiV Healthcare Company Details
11.3.2 ViiV Healthcare Business Overview
11.3.3 ViiV Healthcare HIV Therapeutics Introduction
11.3.4 ViiV Healthcare Revenue in HIV Therapeutics Business (2016-2021)
11.3.5 ViiV Healthcare Recent Development
11.4 AbbVie
11.4.1 AbbVie Company Details
11.4.2 AbbVie Business Overview
11.4.3 AbbVie HIV Therapeutics Introduction
11.4.4 AbbVie Revenue in HIV Therapeutics Business (2016-2021)
11.4.5 AbbVie Recent Development
11.5 F. Hoffmann-La Roche Ltd.
11.5.1 F. Hoffmann-La Roche Ltd. Company Details
11.5.2 F. Hoffmann-La Roche Ltd. Business Overview
11.5.3 F. Hoffmann-La Roche Ltd. HIV Therapeutics Introduction
11.5.4 F. Hoffmann-La Roche Ltd. Revenue in HIV Therapeutics Business (2016-2021)
11.5.5 F. Hoffmann-La Roche Ltd. Recent Development
11.6 Teva Pharmaceutical Industries Ltd.
11.6.1 Teva Pharmaceutical Industries Ltd. Company Details
11.6.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.6.3 Teva Pharmaceutical Industries Ltd. HIV Therapeutics Introduction
11.6.4 Teva Pharmaceutical Industries Ltd. Revenue in HIV Therapeutics Business (2016-2021)
11.6.5 Teva Pharmaceutical Industries Ltd. Recent Development
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Details
11.7.2 Bristol-Myers Squibb Business Overview
11.7.3 Bristol-Myers Squibb HIV Therapeutics Introduction
11.7.4 Bristol-Myers Squibb Revenue in HIV Therapeutics Business (2016-2021)
11.7.5 Bristol-Myers Squibb Recent Development
11.8 Gilead Sciences
11.8.1 Gilead Sciences Company Details
11.8.2 Gilead Sciences Business Overview
11.8.3 Gilead Sciences HIV Therapeutics Introduction
11.8.4 Gilead Sciences Revenue in HIV Therapeutics Business (2016-2021)
11.8.5 Gilead Sciences Recent Development
11.9 Johnson & Johnson
11.9.1 Johnson & Johnson Company Details
11.9.2 Johnson & Johnson Business Overview
11.9.3 Johnson & Johnson HIV Therapeutics Introduction
11.9.4 Johnson & Johnson Revenue in HIV Therapeutics Business (2016-2021)
11.9.5 Johnson & Johnson Recent Development
11.10 Cipla Limited
11.10.1 Cipla Limited Company Details
11.10.2 Cipla Limited Business Overview
11.10.3 Cipla Limited HIV Therapeutics Introduction
11.10.4 Cipla Limited Revenue in HIV Therapeutics Business (2016-2021)
11.10.5 Cipla Limited Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global HIV Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)
Table 3. Key Players of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
Table 4. Key Players of Entry and Fusion Inhibitors
Table 5. Key Players of Protease Inhibitors (PIs)
Table 6. Key Players of Integrase Inhibitors
Table 7. Key Players of Coreceptor Antagonists
Table 8. Global HIV Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global HIV Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global HIV Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global HIV Therapeutics Market Share by Regions (2016-2021)
Table 12. Global HIV Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global HIV Therapeutics Market Share by Regions (2022-2027)
Table 14. HIV Therapeutics Market Trends
Table 15. HIV Therapeutics Market Drivers
Table 16. HIV Therapeutics Market Challenges
Table 17. HIV Therapeutics Market Restraints
Table 18. Global HIV Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global HIV Therapeutics Market Share by Players (2016-2021)
Table 20. Global Top HIV Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HIV Therapeutics as of 2020)
Table 21. Ranking of Global Top HIV Therapeutics Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by HIV Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players HIV Therapeutics Product Solution and Service
Table 25. Date of Enter into HIV Therapeutics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global HIV Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 28. Global HIV Therapeutics Revenue Market Share by Type (2016-2021)
Table 29. Global HIV Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global HIV Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global HIV Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global HIV Therapeutics Revenue Market Share by Application (2016-2021)
Table 33. Global HIV Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global HIV Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America HIV Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 36. North America HIV Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America HIV Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 38. North America HIV Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America HIV Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America HIV Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe HIV Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe HIV Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe HIV Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe HIV Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe HIV Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe HIV Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific HIV Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific HIV Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific HIV Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific HIV Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific HIV Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific HIV Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America HIV Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America HIV Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America HIV Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America HIV Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America HIV Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America HIV Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa HIV Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa HIV Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa HIV Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa HIV Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa HIV Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa HIV Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 65. Boehringer Ingelheim International GmbH Company Details
Table 66. Boehringer Ingelheim International GmbH Business Overview
Table 67. Boehringer Ingelheim International GmbH HIV Therapeutics Product
Table 68. Boehringer Ingelheim International GmbH Revenue in HIV Therapeutics Business (2016-2021) & (US$ Million)
Table 69. Boehringer Ingelheim International GmbH Recent Development
Table 70. Merck & Co. Company Details
Table 71. Merck & Co. Business Overview
Table 72. Merck & Co. HIV Therapeutics Product
Table 73. Merck & Co. Revenue in HIV Therapeutics Business (2016-2021) & (US$ Million)
Table 74. Merck & Co. Recent Development
Table 75. ViiV Healthcare Company Details
Table 76. ViiV Healthcare Business Overview
Table 77. ViiV Healthcare HIV Therapeutics Product
Table 78. ViiV Healthcare Revenue in HIV Therapeutics Business (2016-2021) & (US$ Million)
Table 79. ViiV Healthcare Recent Development
Table 80. AbbVie Company Details
Table 81. AbbVie Business Overview
Table 82. AbbVie HIV Therapeutics Product
Table 83. AbbVie Revenue in HIV Therapeutics Business (2016-2021) & (US$ Million)
Table 84. AbbVie Recent Development
Table 85. F. Hoffmann-La Roche Ltd. Company Details
Table 86. F. Hoffmann-La Roche Ltd. Business Overview
Table 87. F. Hoffmann-La Roche Ltd. HIV Therapeutics Product
Table 88. F. Hoffmann-La Roche Ltd. Revenue in HIV Therapeutics Business (2016-2021) & (US$ Million)
Table 89. F. Hoffmann-La Roche Ltd. Recent Development
Table 90. Teva Pharmaceutical Industries Ltd. Company Details
Table 91. Teva Pharmaceutical Industries Ltd. Business Overview
Table 92. Teva Pharmaceutical Industries Ltd. HIV Therapeutics Product
Table 93. Teva Pharmaceutical Industries Ltd. Revenue in HIV Therapeutics Business (2016-2021) & (US$ Million)
Table 94. Teva Pharmaceutical Industries Ltd. Recent Development
Table 95. Bristol-Myers Squibb Company Details
Table 96. Bristol-Myers Squibb Business Overview
Table 97. Bristol-Myers Squibb HIV Therapeutics Product
Table 98. Bristol-Myers Squibb Revenue in HIV Therapeutics Business (2016-2021) & (US$ Million)
Table 99. Bristol-Myers Squibb Recent Development
Table 100. Gilead Sciences Company Details
Table 101. Gilead Sciences Business Overview
Table 102. Gilead Sciences Revenue in HIV Therapeutics Business (2016-2021) & (US$ Million)
Table 103. Gilead Sciences Recent Development
Table 104. Johnson & Johnson Company Details
Table 105. Johnson & Johnson Business Overview
Table 106. Johnson & Johnson HIV Therapeutics Product
Table 107. Johnson & Johnson Revenue in HIV Therapeutics Business (2016-2021) & (US$ Million)
Table 108. Johnson & Johnson Recent Development
Table 109. Cipla Limited Company Details
Table 110. Cipla Limited Business Overview
Table 111. Cipla Limited HIV Therapeutics Product
Table 112. Cipla Limited Revenue in HIV Therapeutics Business (2016-2021) & (US$ Million)
Table 113. Cipla Limited Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global HIV Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs) Features
Figure 3. Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Features
Figure 4. Entry and Fusion Inhibitors Features
Figure 5. Protease Inhibitors (PIs) Features
Figure 6. Integrase Inhibitors Features
Figure 7. Coreceptor Antagonists Features
Figure 8. Global HIV Therapeutics Market Share by Application: 2020 VS 2027
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Labs Case Studies
Figure 12. HIV Therapeutics Report Years Considered
Figure 13. Global HIV Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global HIV Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global HIV Therapeutics Market Share by Regions: 2020 VS 2027
Figure 16. Global HIV Therapeutics Market Share by Regions (2022-2027)
Figure 17. Global HIV Therapeutics Market Share by Players in 2020
Figure 18. Global Top HIV Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HIV Therapeutics as of 2020
Figure 19. The Top 10 and 5 Players Market Share by HIV Therapeutics Revenue in 2020
Figure 20. Global HIV Therapeutics Revenue Market Share by Type (2016-2021)
Figure 21. Global HIV Therapeutics Revenue Market Share by Type (2022-2027)
Figure 22. North America HIV Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America HIV Therapeutics Market Share by Type (2016-2027)
Figure 24. North America HIV Therapeutics Market Share by Application (2016-2027)
Figure 25. North America HIV Therapeutics Market Share by Country (2016-2027)
Figure 26. United States HIV Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada HIV Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe HIV Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe HIV Therapeutics Market Share by Type (2016-2027)
Figure 30. Europe HIV Therapeutics Market Share by Application (2016-2027)
Figure 31. Europe HIV Therapeutics Market Share by Country (2016-2027)
Figure 32. Germany HIV Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France HIV Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. HIV Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy HIV Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia HIV Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic HIV Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific HIV Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific HIV Therapeutics Market Share by Type (2016-2027)
Figure 40. Asia-Pacific HIV Therapeutics Market Share by Application (2016-2027)
Figure 41. Asia-Pacific HIV Therapeutics Market Share by Region (2016-2027)
Figure 42. China HIV Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan HIV Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea HIV Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia HIV Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India HIV Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia HIV Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America HIV Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America HIV Therapeutics Market Share by Type (2016-2027)
Figure 50. Latin America HIV Therapeutics Market Share by Application (2016-2027)
Figure 51. Latin America HIV Therapeutics Market Share by Country (2016-2027)
Figure 52. Mexico HIV Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil HIV Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa HIV Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa HIV Therapeutics Market Share by Type (2016-2027)
Figure 56. Middle East & Africa HIV Therapeutics Market Share by Application (2016-2027)
Figure 57. Middle East & Africa HIV Therapeutics Market Share by Country (2016-2027)
Figure 58. Turkey HIV Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia HIV Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE HIV Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Boehringer Ingelheim International GmbH Revenue Growth Rate in HIV Therapeutics Business (2016-2021)
Figure 62. Merck & Co. Revenue Growth Rate in HIV Therapeutics Business (2016-2021)
Figure 63. ViiV Healthcare Revenue Growth Rate in HIV Therapeutics Business (2016-2021)
Figure 64. AbbVie Revenue Growth Rate in HIV Therapeutics Business (2016-2021)
Figure 65. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in HIV Therapeutics Business (2016-2021)
Figure 66. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in HIV Therapeutics Business (2016-2021)
Figure 67. Bristol-Myers Squibb Revenue Growth Rate in HIV Therapeutics Business (2016-2021)
Figure 68. Gilead Sciences Revenue Growth Rate in HIV Therapeutics Business (2016-2021)
Figure 69. Johnson & Johnson Revenue Growth Rate in HIV Therapeutics Business (2016-2021)
Figure 70. Cipla Limited Revenue Growth Rate in HIV Therapeutics Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed